Brenntag and dsm-firmenich Formed Global Partnership
The companies have launched a new co-brand to distribute high-purity vitamins for bioprocessing applications.
Updated on Oct. 4, 2026 in Consumer Goods
Live Poll
Do you believe partnerships between large global companies generally benefit consumers in the long run?
Brenntag Pharma and dsm-firmenich have established a global distribution partnership for GMP-grade vitamins. The agreement centers on a new co-brand, BYPHAR powered by Biond, which features eight specialized products.
Why it matters
This partnership aims to streamline the supply of high-purity vitamins essential for cell culture, feed media, and upstream bioprocessing. It serves the manufacturing needs for biologics, vaccines, and cell therapies on a global scale.
The new co-brand, BYPHAR powered by Biond, includes eight high-purity vitamin products. The collaboration builds upon a 30-year professional relationship between the two companies.
The players
Brenntag
Brenntag is a global chemical and ingredients distributor that provides comprehensive supply chain solutions to various industries.
dsm-firmenich
dsm-firmenich is a leading innovator in health, nutrition, and beauty, specializing in the science of ingredients for human and animal health.
The details
Under the new agreement, Brenntag holds exclusive distribution rights for the Biond portfolio across North America, Latin America, Europe, the Middle East, Africa, and Asia-Pacific. These vitamins are specifically developed for complex bioprocessing workflows.
Timeline
The partnership agreement was publicly announced on October 4, 2026.
Market Landscape
This collaboration strengthens the market position of both entities by leveraging long-standing expertise to capture share in the highly regulated bioprocessing sector. It reflects a wider industry strategy to consolidate global distribution channels for essential life science materials.
Customers in the biopharma sector can expect improved access to the Biond vitamin portfolio through Brenntag's extensive global logistics network. This integration is designed to simplify procurement processes for manufacturers of biologics and cell therapies.
The takeaway
The formalization of a three-decade professional relationship highlights the growing importance of supply chain security in the bioprocessing market. Companies relying on high-purity inputs should monitor how these distribution changes impact global availability and lead times for essential materials.
Further reading
For more on industry shifts, visit the Consumer Goods section.
Source note: This article includes information reported by Pharmafile.
Live Poll
Do you believe partnerships between large global companies generally benefit consumers in the long run?
